Galectins News and Research

RSS
Galectins play a key role in the degeneration of cartilage in osteoarthritis

Galectins play a key role in the degeneration of cartilage in osteoarthritis

Scientists define key binding characteristics of protein associated with heart disease and breast cancer

Scientists define key binding characteristics of protein associated with heart disease and breast cancer

Complex sugar molecules could help in early detection of tumors

Complex sugar molecules could help in early detection of tumors

Study reveals potential therapeutic targets for treating patients who carry IFNGR receptor mutation

Study reveals potential therapeutic targets for treating patients who carry IFNGR receptor mutation

Carbohydrate-binding protein controls inflammation in osteoarthritis patients

Carbohydrate-binding protein controls inflammation in osteoarthritis patients

Glycan binding proteins modify parasite infection in cells of the heart muscle

Glycan binding proteins modify parasite infection in cells of the heart muscle

Carbohydrate-binding proteins fill in gaps in immune defenses

Carbohydrate-binding proteins fill in gaps in immune defenses

Galectins play an important role in development of osteoarthrosis

Galectins play an important role in development of osteoarthrosis

Galectin Therapeutics to initiate GM-CT-01 Phase 1/2 combination study in advanced MM

Galectin Therapeutics to initiate GM-CT-01 Phase 1/2 combination study in advanced MM

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin second quarter net loss increases to $3.9 million

Galectin second quarter net loss increases to $3.9 million

Galectin, University of Michigan enter collaboration to study role of Galectins in cardiovascular disease

Galectin, University of Michigan enter collaboration to study role of Galectins in cardiovascular disease

Galectin strengthens cancer drug patent portfolio in Europe

Galectin strengthens cancer drug patent portfolio in Europe

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Ludwig Institute demonstrates ability of DAVANAT to enhance efficacy of T-lymphocytes to kill tumor cells

Ludwig Institute demonstrates ability of DAVANAT to enhance efficacy of T-lymphocytes to kill tumor cells

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals to begin DAVANAT Phase III development program following FDA approval

Pro-Pharmaceuticals to begin DAVANAT Phase III development program following FDA approval

Pro-Pharmaceuticals third quarter net loss decreases to $1,899,000

Pro-Pharmaceuticals third quarter net loss decreases to $1,899,000

Pro-Pharmaceuticals awarded $489,000 in federal grants under Qualifying Therapeutic Discovery Project

Pro-Pharmaceuticals awarded $489,000 in federal grants under Qualifying Therapeutic Discovery Project

Pro-Pharmaceuticals ships first commercial order of DAVANAT to PROCAPS in Colombia

Pro-Pharmaceuticals ships first commercial order of DAVANAT to PROCAPS in Colombia